1. Home
  2. BBLG

as of 11-19-2026 3:58pm EST

$0.28
$0.01
-2.13%
Stocks Health Care Industrial Specialties Nasdaq

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Founded: 2004 Country:
United States
United States
Employees: N/A City: BURLINGTON
Market Cap: 1.2M IPO Year: 2014
Target Price: N/A AVG Volume (30 days): 409.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.88 EPS Growth: 45.13
52 Week Low/High: $0.27 - $4.78 Next Earning Date: 10-26-2026
Revenue: $1,070,000,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: -0.32 Index: N/A
Free Cash Flow: -2691654.0 FCF Growth: N/A

Share on Social Networks: